Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

TIMI-IIA finds enoxaparin promising

July 1, 1997

New indication for enoxaparin recommended for approval

June 27, 1997

Thrombin inhibitors from Akzo Nobel

June 27, 1997

Orally active antithrombotic agents described by Pfizer

June 27, 1997

S.c. lepirudin vs. i.v. heparin for deep vein thrombosis

June 23, 1997

NicOx reveals antiinflammatory/antithrombotic compounds with low toxicity

June 20, 1997

RPR seeks approval for enoxaparin for unstable angina in Europe

June 18, 1997

3-Dimensional Pharmaceuticals licenses thrombin inhibitors to Wyeth-Ayerst

June 17, 1997

Chimeric molecule shows promise as thrombolytic therapy

June 11, 1997

Thomae prepares fibrinogen receptor antagonists

June 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.